• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保乳术后同侧乳腺肿瘤复发可预测后续死亡率:一项随机试验的结果。安大略临床肿瘤学组的研究人员。

Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.

作者信息

Whelan T, Clark R, Roberts R, Levine M, Foster G

机构信息

OCTRF, Hamilton Regional Cancer Centre, Ontario, Canada.

出版信息

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):11-6. doi: 10.1016/0360-3016(94)90513-4.

DOI:10.1016/0360-3016(94)90513-4
PMID:8083103
Abstract

PURPOSE

To determine whether ipsilateral breast tumor recurrence (IBTR) postlumpectomy was independently predictive of distant relapse and mortality in women with node negative breast cancer.

METHODS AND MATERIALS

A randomized trial was conducted in Ontario between 1984 and 1989, in which 837 women with node negative disease who had undergone lumpectomy and axillary dissection were randomized to either postoperative radiation (40 Gy in 16 fractions to the whole breast, followed by a boost of 12.5 Gy in five fractions to the primary site), or no further treatment. A Cox proportional hazards regression analysis was performed for the endpoints mortality and distant relapse using the fixed covariates, treatment, age, tumor size, estrogen receptor status, progesterone receptor status, and nuclear grade; and the time dependent variable IBTR.

RESULTS

The analysis was based on 799 patients for which all fixed covariate data was available. Median follow-up was 66 months. The cumulative rate of IBTR at 5 years was significantly greater for the no treatment group compared to the radiation group; 30% vs. 8% respectively (p < 0.0001). No difference was detected in overall survival between the treatment groups (p = 0.45). Significant independent predictors for mortality were nuclear grade, high vs. medium or low (relative risk (RR) = 2.28, p = 0.0001); and tumor size > or = 2 cm. vs. < 2 cm. (RR = 1.64, p = 0.01). In addition, IBTR predicted increased mortality (RR = 2.18, p < 0.0006). Similar results were observed for distant relapse. An IBTR within 1 year of surgery was associated with a higher risk of distant relapse and mortality.

CONCLUSION

Local breast recurrence following lumpectomy is associated with an increased risk of distant relapse and death.

摘要

目的

确定保乳手术后同侧乳腺肿瘤复发(IBTR)是否能独立预测无淋巴结转移乳腺癌女性的远处复发和死亡率。

方法与材料

1984年至1989年在安大略省进行了一项随机试验,837例接受保乳手术和腋窝清扫的无淋巴结转移疾病女性被随机分为术后放疗组(全乳16次分割照射40 Gy,随后对原发部位5次分割追加照射12.5 Gy)或不进行进一步治疗组。使用固定协变量(治疗、年龄、肿瘤大小、雌激素受体状态、孕激素受体状态和核分级)以及时间依赖性变量IBTR,对死亡率和远处复发终点进行Cox比例风险回归分析。

结果

分析基于799例可获得所有固定协变量数据的患者。中位随访时间为66个月。未治疗组5年时IBTR的累积发生率显著高于放疗组;分别为30%和8%(p < 0.0001)。治疗组之间总生存率无差异(p = 0.45)。死亡率的显著独立预测因素为核分级,高分级与中分级或低分级相比(相对风险(RR)= 2.28,p = 0.0001);以及肿瘤大小≥2 cm与<2 cm相比(RR = 1.64,p = 0.01)。此外,IBTR可预测死亡率增加(RR = 2.18,p < 0.0006)。远处复发也观察到类似结果。术后1年内发生IBTR与远处复发和死亡风险较高相关。

结论

保乳术后局部乳腺复发与远处复发和死亡风险增加相关。

相似文献

1
Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.保乳术后同侧乳腺肿瘤复发可预测后续死亡率:一项随机试验的结果。安大略临床肿瘤学组的研究人员。
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):11-6. doi: 10.1016/0360-3016(94)90513-4.
2
Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.保乳手术及腋窝淋巴结清扫术后对淋巴结阴性乳腺癌进行乳腺放疗的随机临床试验:最新进展。安大略临床肿瘤学组
J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64. doi: 10.1093/jnci/88.22.1659.
3
Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.腋窝淋巴结阴性乳腺癌患者同侧乳腺肿瘤复发的发生率、预后因素及其对疾病特异性生存影响的分析:一项前瞻性队列研究
Breast Cancer Res. 2006;8(4):R44. doi: 10.1186/bcr1531.
4
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.基于真性复发和新发原发性肿瘤分类的保乳治疗后同侧乳腺肿瘤复发分析
Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104.
5
[Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].保乳治疗后同侧乳腺肿瘤复发患者的临床特征与预后
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):352-358. doi: 10.3760/cma.j.issn.0253-3766.2018.05.007.
6
Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.同侧乳腺肿瘤复发后单纯再次行保乳术,死亡率增加。
Oncologist. 2019 Sep;24(9):e818-e827. doi: 10.1634/theoncologist.2018-0606. Epub 2019 Mar 6.
7
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.早期乳腺癌保乳手术及放疗后的局部复发和远处转移
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38. doi: 10.1016/s0360-3016(98)00365-4.
8
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.早期乳腺癌保乳治疗后同侧乳腺肿瘤复发(IBTR):危险因素及对远处转移的影响
Cancer. 2006 Jan 1;106(1):35-41. doi: 10.1002/cncr.21551.
9
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.手术切缘阳性和同侧乳腺肿瘤复发可预测保乳治疗后的疾病特异性生存。
Cancer. 2003 Feb 15;97(4):926-33. doi: 10.1002/cncr.11222.
10
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.

引用本文的文献

1
The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy.2024年阿西西乳腺癌智库:聚焦保乳治疗后瘤床加量放疗的应用
Breast. 2025 Apr;80:103881. doi: 10.1016/j.breast.2025.103881. Epub 2025 Jan 20.
2
Patient characteristics and clinical factors affecting lumpectomy cavity volume: implications for partial breast irradiation.影响乳房肿瘤切除术腔体积的患者特征和临床因素:对部分乳腺照射的影响
Front Oncol. 2023 May 23;13:1118713. doi: 10.3389/fonc.2023.1118713. eCollection 2023.
3
Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
保乳术后腋窝淋巴结阴性的同侧乳腺肿瘤局部复发患者省略腋窝手术:在肿瘤学上是否安全?
Breast Cancer Res Treat. 2022 Nov;196(1):97-109. doi: 10.1007/s10549-022-06708-y. Epub 2022 Aug 30.
4
Interactive exploration of a global clinical network from a large breast cancer cohort.来自大型乳腺癌队列的全球临床网络的交互式探索。
NPJ Digit Med. 2022 Aug 10;5(1):113. doi: 10.1038/s41746-022-00647-0.
5
Repeat Breast-Conserving Surgery Versus Salvage Mastectomy for Ipsilateral Breast Tumour Recurrence After Breast-Conserving Surgery in Breast Cancer Patients: A Meta-Analysis.乳腺癌患者保乳手术后同侧乳腺肿瘤复发:保乳手术与挽救性乳房切除术的Meta分析
Front Oncol. 2021 Nov 23;11:734719. doi: 10.3389/fonc.2021.734719. eCollection 2021.
6
Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer.指南一致的治疗可预测生存:一项基于国家癌症数据库的新型局部区域和全身治疗综合评分的验证研究,纳入了早期乳腺癌女性患者。
Breast Cancer. 2021 May;28(3):698-709. doi: 10.1007/s12282-020-01206-9. Epub 2021 Jan 4.
7
Long-term survival outcomes of repeat lumpectomy for ipsilateral breast tumor recurrence: a propensity score-matched analysis.重复保乳术治疗同侧乳房肿瘤复发的长期生存结果:倾向评分匹配分析。
Breast Cancer Res Treat. 2021 Jan;185(1):155-164. doi: 10.1007/s10549-020-05932-8. Epub 2020 Sep 15.
8
Prognostic study for isolated local recurrence operated with salvage excision in hormone-receptor-positive patients with invasive breast cancer after primary breast surgery.激素受体阳性浸润性乳腺癌患者在初次乳腺手术后接受挽救性切除治疗的孤立性局部复发的预后研究。
Biomed J. 2020 Feb;43(1):83-93. doi: 10.1016/j.bj.2019.07.002. Epub 2020 Feb 21.
9
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach.新辅助化疗治疗乳腺癌患者局部复发时间对转移发生的影响:随机森林生存分析方法。
PLoS One. 2019 Jan 23;14(1):e0208807. doi: 10.1371/journal.pone.0208807. eCollection 2019.
10
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.乳腺癌的多学科筛查、诊断、治疗及随访。德国妇科和产科学会(DGGG)与德国癌症协会(DKG)指南(S3级,德国医学科学信息平台AWMF注册号032/045OL,2017年12月) - 第2部分:原发性、复发性和晚期乳腺癌治疗建议
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26.